Breakthrough Cancer Research has allocated €1 million in funding, with co-support from industry and other charities Prof Jacintha O’Sullivan and PhD student Lorraine Smith announced a new treatment at the bench which aims to target inflammation in Barrett’s patients, funded by Breakthrough Cancer Research, before World Barrett’s Oesophagus Day on May 16. Pictured at the Trinity Translational Medicine Institute at St James’s Hospital, the researchers are part of the recently established All-Ireland AllCaN-Oesophageal Network, a unique network of scientist, clinicians, industry partners and patent groups across the island of Ireland, focused on accelerating discoveries across oesophageal cancer patient journey from cancer prevention, diagnosis, treatment, and survivorship. Breakthrough Cancer Research has allocated €1 million in funding, with co-support from industry and other charities such as the Oesophageal Cancer Fund and Cross, to deliver impact for Barrett’s and Oesophageal cancer patients.
For more see breakthroughcancerresearch.ie ..
